Biochemical Pharmacology, volume 169, pages 113638

Advances and challenges in studying noncoding RNA regulation of drug metabolism and development of RNA therapeutics

Ning Baitang 1
Yu Dianke 2
Yu Ai-Ming 3
1
 
National Center for Toxicological Research (NCTR), US Food and Drug Administration, Jefferson, AR 72079, USA
3
 
Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, CA 95817, USA
Publication typeJournal Article
Publication date2019-11-01
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor5.8
ISSN00062952, 18732968
Biochemistry
Pharmacology
Abstract
Accumulating evidence has demonstrated that genome-derived noncoding RNAs (ncRNAs) play important roles in modulating inter-individual variations observed in drug metabolism and disposition by controlling the expression of genes coding drug metabolizing enzymes and transporters (DMETs) and relevant nuclear receptors (NRs). With the understanding of novel ncRNA regulatory mechanisms and significance in the control of disease initiation and progression, RNA-based therapies are under active investigation that may expand the druggable targets from conventional proteins to RNAs and the genome for the treatment of human diseases. Herein we provide an overview of research strategies, approaches and their limitations in biochemical and pharmacological studies pertaining to ncRNA functions in the regulation of drug and nutrient metabolism and disposition, and discussion on the promise and challenges in developing RNA therapeutics.

Citations by journals

1
2
3
4
Frontiers in Genetics
Frontiers in Genetics, 4, 10.81%
Frontiers in Genetics
4 publications, 10.81%
Genes
Genes, 3, 8.11%
Genes
3 publications, 8.11%
Nucleic Acids Research
Nucleic Acids Research, 3, 8.11%
Nucleic Acids Research
3 publications, 8.11%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 2, 5.41%
International Journal of Molecular Sciences
2 publications, 5.41%
Journal of Cancer Research and Clinical Oncology
Journal of Cancer Research and Clinical Oncology, 1, 2.7%
Journal of Cancer Research and Clinical Oncology
1 publication, 2.7%
Drug Metabolism and Disposition
Drug Metabolism and Disposition, 1, 2.7%
Drug Metabolism and Disposition
1 publication, 2.7%
Molecular Pharmacology
Molecular Pharmacology, 1, 2.7%
Molecular Pharmacology
1 publication, 2.7%
Non-coding RNA
Non-coding RNA, 1, 2.7%
Non-coding RNA
1 publication, 2.7%
Cancers
Cancers, 1, 2.7%
Cancers
1 publication, 2.7%
Pharmaceutics
Pharmaceutics, 1, 2.7%
Pharmaceutics
1 publication, 2.7%
Antioxidants
Antioxidants, 1, 2.7%
Antioxidants
1 publication, 2.7%
Frontiers in Immunology
Frontiers in Immunology, 1, 2.7%
Frontiers in Immunology
1 publication, 2.7%
Frontiers in Oncology
Frontiers in Oncology, 1, 2.7%
Frontiers in Oncology
1 publication, 2.7%
Archives of Toxicology
Archives of Toxicology, 1, 2.7%
Archives of Toxicology
1 publication, 2.7%
Current Clinical Microbiology Reports
Current Clinical Microbiology Reports, 1, 2.7%
Current Clinical Microbiology Reports
1 publication, 2.7%
Advanced Drug Delivery Reviews
Advanced Drug Delivery Reviews, 1, 2.7%
Advanced Drug Delivery Reviews
1 publication, 2.7%
Life Sciences
Life Sciences, 1, 2.7%
Life Sciences
1 publication, 2.7%
Pharmacology and Therapeutics
Pharmacology and Therapeutics, 1, 2.7%
Pharmacology and Therapeutics
1 publication, 2.7%
Molecular Therapy - Oncolytics
Molecular Therapy - Oncolytics, 1, 2.7%
Molecular Therapy - Oncolytics
1 publication, 2.7%
Expert Opinion on Drug Metabolism and Toxicology
Expert Opinion on Drug Metabolism and Toxicology, 1, 2.7%
Expert Opinion on Drug Metabolism and Toxicology
1 publication, 2.7%
Drug Metabolism Reviews
Drug Metabolism Reviews, 1, 2.7%
Drug Metabolism Reviews
1 publication, 2.7%
Toxicological Sciences
Toxicological Sciences, 1, 2.7%
Toxicological Sciences
1 publication, 2.7%
Journal of Thoracic Disease
Journal of Thoracic Disease, 1, 2.7%
Journal of Thoracic Disease
1 publication, 2.7%
Experimental and Therapeutic Medicine
Experimental and Therapeutic Medicine, 1, 2.7%
Experimental and Therapeutic Medicine
1 publication, 2.7%
Non-coding RNA Research
Non-coding RNA Research, 1, 2.7%
Non-coding RNA Research
1 publication, 2.7%
Annual Review of Pharmacology and Toxicology
Annual Review of Pharmacology and Toxicology, 1, 2.7%
Annual Review of Pharmacology and Toxicology
1 publication, 2.7%
Biochimica et Biophysica Acta - Reviews on Cancer
Biochimica et Biophysica Acta - Reviews on Cancer, 1, 2.7%
Biochimica et Biophysica Acta - Reviews on Cancer
1 publication, 2.7%
1
2
3
4

Citations by publishers

1
2
3
4
5
6
7
8
9
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 9, 24.32%
Multidisciplinary Digital Publishing Institute (MDPI)
9 publications, 24.32%
Frontiers Media S.A.
Frontiers Media S.A., 6, 16.22%
Frontiers Media S.A.
6 publications, 16.22%
Elsevier
Elsevier, 5, 13.51%
Elsevier
5 publications, 13.51%
Oxford University Press
Oxford University Press, 4, 10.81%
Oxford University Press
4 publications, 10.81%
Springer Nature
Springer Nature, 3, 8.11%
Springer Nature
3 publications, 8.11%
American Society for Pharmacology and Experimental Therapeutics
American Society for Pharmacology and Experimental Therapeutics, 2, 5.41%
American Society for Pharmacology and Experimental Therapeutics
2 publications, 5.41%
Taylor & Francis
Taylor & Francis, 2, 5.41%
Taylor & Francis
2 publications, 5.41%
AME Publishing Company
AME Publishing Company, 1, 2.7%
AME Publishing Company
1 publication, 2.7%
Spandidos Publications
Spandidos Publications, 1, 2.7%
Spandidos Publications
1 publication, 2.7%
KeAi Communications Co.
KeAi Communications Co., 1, 2.7%
KeAi Communications Co.
1 publication, 2.7%
Annual Reviews
Annual Reviews, 1, 2.7%
Annual Reviews
1 publication, 2.7%
1
2
3
4
5
6
7
8
9
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Ning B., Yu D., Yu A. Advances and challenges in studying noncoding RNA regulation of drug metabolism and development of RNA therapeutics // Biochemical Pharmacology. 2019. Vol. 169. p. 113638.
GOST all authors (up to 50) Copy
Ning B., Yu D., Yu A. Advances and challenges in studying noncoding RNA regulation of drug metabolism and development of RNA therapeutics // Biochemical Pharmacology. 2019. Vol. 169. p. 113638.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.bcp.2019.113638
UR - https://doi.org/10.1016%2Fj.bcp.2019.113638
TI - Advances and challenges in studying noncoding RNA regulation of drug metabolism and development of RNA therapeutics
T2 - Biochemical Pharmacology
AU - Ning, Baitang
AU - Yu, Dianke
AU - Yu, Ai-Ming
PY - 2019
DA - 2019/11/01 00:00:00
PB - Elsevier
SP - 113638
VL - 169
PMID - 31518552
SN - 0006-2952
SN - 1873-2968
ER -
BibTex
Cite this
BibTex Copy
@article{2019_Ning,
author = {Baitang Ning and Dianke Yu and Ai-Ming Yu},
title = {Advances and challenges in studying noncoding RNA regulation of drug metabolism and development of RNA therapeutics},
journal = {Biochemical Pharmacology},
year = {2019},
volume = {169},
publisher = {Elsevier},
month = {nov},
url = {https://doi.org/10.1016%2Fj.bcp.2019.113638},
pages = {113638},
doi = {10.1016/j.bcp.2019.113638}
}
Found error?